Sowell Financial Services LLC Athenex, Inc. Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$4.08 - $14.75 $4,936 - $17,847	-1,210 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.26 - $14.55 $3,129 - $4,437	305 Added 33.7%	1,210 $15,000
Q2 2020 Aug 13, 2020	SELL	$7.11 - $13.76 $25,553 - $49,453	-3,594 Reduced 79.88%	905 $12,000
Q1 2020 May 12, 2020	SELL	$5.71 - $15.85 $616 - $1,711	-108 Reduced 2.34%	4,499 $35,000
Q4 2019 Feb 07, 2020	BUY	$9.6 - $17.75 $44,227 - $81,774	4,607 New	4,607 $70,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.